Categories Earnings, Technology
Earnings Summary: Catalent (CTLT) slips to a loss in Q2; revenue down 10%
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, on Friday reported a net loss for the second quarter of 2024, reflecting a decline in revenues.
- Net revenue came in at $1.03 billion in the December quarter, which is down 10% from the prior year quarter
- The company reported a net loss of $204 million or $1.12 per share for the second quarter, compared to earnings of $81 million or $0.44 per share in Q2 2023
- On an adjusted basis, loss per share was $0.24 in Q2, vs. a profit of $0.67 per share a year earlier
- Q2 adjusted EBITDA fell 56% from last year to $124 million as reported, and dropped 57% in constant currency
- During the quarter, Catalent raised $600 million in term loans and used the proceeds to pay down debt
- Recently, the company agreed to be acquired by Novo Holdings an all-cash deal that values it at $16.5 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
